Ambea AB (publ) (STO:AMBEA)
Sweden · Delayed Price · Currency is SEK 141.10
+2.10 (1.51%)
At close: Nov 28, 2025
Ambea AB Market Cap
Ambea AB has a market cap or net worth of 11.87 billion as of November 28, 2025. Its market cap has increased by 48.11% in one year.
Market Cap
11.87B
Enterprise Value
25.00B
Revenue
15.61B
Ranking
n/a
PE Ratio
17.31
Stock Price
141.10
Market Cap Chart
Since March 31, 2017, Ambea AB's market cap has increased from 5.58B to 11.87B, an increase of 112.73%. That is a compound annual growth rate of 9.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 11.87B | 46.57% |
| Dec 30, 2024 | 8.10B | 71.86% |
| Dec 29, 2023 | 4.71B | 13.21% |
| Dec 30, 2022 | 4.16B | -27.18% |
| Dec 30, 2021 | 5.71B | -7.04% |
| Dec 30, 2020 | 6.15B | -17.13% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 117.60B |
| Getinge AB | 57.50B |
| Sectra AB | 55.60B |
| Camurus AB | 36.33B |
| Asker Healthcare Group AB | 35.52B |
| Medicover AB | 34.59B |
| BioArctic AB | 25.78B |
| AddLife AB | 22.67B |